ABIGAIL OLIVER: Open Payments
NPI 1700218914 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 7 companies in 2025. Trend: 2023 $270 · 2024 $335 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 5 | $102 |
| Novo Nordisk Inc | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Seqirus USA Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: VYVGART HYTRULO, Wegovy, Flucelvax, CAPLYTA, VRAYLAR, Ozempic, BREZTRI, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
